[HTML][HTML] The mechanisms of disease caused by Acinetobacter baumannii
Acinetobacter baumannii is a Gram negative opportunistic pathogen that has demonstrated
a significant insurgence in the prevalence of infections over recent decades. With only a …
a significant insurgence in the prevalence of infections over recent decades. With only a …
Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
Acinetobacter baumannii, once considered a low-category pathogen, has emerged as an
obstinate infectious agent. The scientific community is paying more attention to this …
obstinate infectious agent. The scientific community is paying more attention to this …
Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans
Tigecycline is a last-resort antibiotic that is used to treat severe infections caused by
extensively drug-resistant bacteria. tet (X) has been shown to encode a flavin-dependent …
extensively drug-resistant bacteria. tet (X) has been shown to encode a flavin-dependent …
2010 年中国CHINET 鲍曼不动杆菌耐药性监测
习慧明， 徐英春， 朱德妹， 汪复， 倪语星， 孙景勇… - 中国感染与化疗 …, 2012 - cqvip.com
目的了解2010 年中国不同地区14 所教学医院临床分离鲍曼不动杆菌的耐药性. 方法收集14
所教学医院临床分离的非重复不动杆菌属共5523 株, 其中鲍曼不动杆菌4949 株, 按照统一方案 …
所教学医院临床分离的非重复不动杆菌属共5523 株, 其中鲍曼不动杆菌4949 株, 按照统一方案 …
Treatment of infections caused by multidrug-resistant gram-negative bacteria: Report of the British society for antimicrobial chemotherapy/healthcare infection society …
PM Hawkey, RE Warren, DM Livermore… - Journal of …, 2018 - academic.oup.com
Abstract The Working Party makes more than 100 tabulated recommendations in
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …
[HTML][HTML] Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features
SB Almasaudi - Saudi journal of biological sciences, 2018 - Elsevier
The genus Acinetobacter is a major cause of nosocomial infections; it is increasingly being
associated with various epidemics and has become a widespread concern in a variety of …
associated with various epidemics and has become a widespread concern in a variety of …
2007 年中国CHINET 鲍曼不动杆菌耐药性监测
史俊艳， 张小江， 徐英春， 俞云松， 杨青， 汪复… - 中国感染与化疗 …, 2009 - cqvip.com
目的监测2007 年中国不同地区12 所医院临床分离鲍曼不动杆菌的耐药性.
方法收集临床分离的非重复鲍曼不动杆菌2718 株, 采用纸片扩散法测定菌株对抗菌药物的敏感 …
方法收集临床分离的非重复鲍曼不动杆菌2718 株, 采用纸片扩散法测定菌株对抗菌药物的敏感 …
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
In the face of diminishing therapeutic options for the treatment of infections caused by
multidrug-resistant, Gram-negative bacteria, clinicians are increasingly using colistin and …
multidrug-resistant, Gram-negative bacteria, clinicians are increasingly using colistin and …
Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species
DJ Weber, WA Rutala, MB Miller, K Huslage… - American journal of …, 2010 - Elsevier
Health care-associated infections (HAI) remain a major cause of patient morbidity and
mortality. Although the main source of nosocomial pathogens is likely the patient's …
mortality. Although the main source of nosocomial pathogens is likely the patient's …
鲍曼不动杆菌抗生素多重耐药性: 耐药机制与感染治疗对策
凌保东 - 中国抗生素杂志, 2010 - cqvip.com
多重以及泛耐药鲍曼不动杆菌导致的感染流行已成为全球关注的公共卫生问题.
大多数细菌耐药基因与表型特征均充分反映在耐药鲍曼不动杆菌. 鲍曼不动杆菌的外膜通透屏障 …
大多数细菌耐药基因与表型特征均充分反映在耐药鲍曼不动杆菌. 鲍曼不动杆菌的外膜通透屏障 …